Efficacy of a BCNU-based high dose conditioning regimen (CBV1) followed by autologous hematopoietic stem cell transplantation (HSCT) in relapsed or refractory Hodgkin's disease (HD).

被引：0
|
作者：
Qazilbash, MH [1 ]
Lynch, JP [1 ]
Beall, CL [1 ]
Auber, M [1 ]
Weisenborn, R [1 ]
Bunner, P [1 ]
Hobbs, G [1 ]
Ericson, SG [1 ]
机构：
[1] W Virginia Univ, BMT Sect, Morgantown, WV 26506 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5369
引用
收藏
页码：374B / 374B
页数：1
相关论文
共 50 条
  • [21] High dose sequential (HDS) followed by autologous hematopoietic stem cell transplantation (AHSCT) for salvage treatment of Hodgkin's disease (HD): A Brazilian experience
    Duarte, Bruno K. L.
    Valente, I. S.
    Vigorito, Afonso C.
    Aranha, Francisco J. P.
    Oliveira, Gislaine B.
    Miranda, Eliana C. M.
    Lorand-Metze, Irene
    Pagnano, Katia B. B.
    De Souza, Cannino A.
    BLOOD, 2007, 110 (11) : 357B - 357B
  • [22] Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma
    A P Rapoport
    C Guo
    A Badros
    R Hakimian
    G Akpek
    E Kiggundu
    B Meisenberg
    H Mannuel
    N Takebe
    R Fenton
    J Bolaños-Meade
    M Heyman
    I Gojo
    K Ruehle
    S Natt
    B Ratterree
    T Withers
    C Sarkodee-Adoo
    G L Phillips
    G Tricot
    Bone Marrow Transplantation, 2004, 34 : 883 - 890
  • [23] Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma
    Rapoport, AP
    Guo, C
    Badros, A
    Hakimian, R
    Akpek, G
    Kiggundu, E
    Meisenberg, B
    Mannuel, H
    Takebe, N
    Fenton, R
    Bolaños-Meade, J
    Heyman, M
    Gojo, I
    Ruehle, K
    Natt, S
    Ratterree, B
    Withers, T
    Sarkodee-Adoo, C
    Phillips, GL
    Tricot, G
    BONE MARROW TRANSPLANTATION, 2004, 34 (10) : 883 - 890
  • [24] Flamsa-based High-dose Sequential Conditioning Regimen followed by Allogeneic Hematopoietic Stem Cell Transplantation(ALLO-HSCT): Is It Effective in Patients with Primary Refractory or Relapsed Acute Leukemia?
    Seval, Guldane Cengiz
    Kircali, Ekin
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Yuksel, Meltem Kurt
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Gurman, Gunhan
    Ilhan, Osman
    Akan, Hamdi
    Beksac, Meral
    Topcuoglu, Pervin
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 305 - 306
  • [25] Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma
    Shabbir-Moosajee, Munira
    Jehangir, Samad
    Sawani, Sobiya
    Muhammed, Tariq
    Ali, Natasha
    Sheikh, Usman
    Adil, Salman
    BLOOD RESEARCH, 2019, 54 (02) : 108 - 113
  • [26] Outcomes of autologous stem cell transplantation with CEAM conditioning in relapsed or refractory Hodgkin's lymphoma
    Hedayati-Asl, A. A.
    Mehrvar, A.
    Tashvighi, M.
    Faranoush, M.
    Fallah, V.
    Zangooei, R.
    Nikfarjam, H.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S373 - S373
  • [27] Refractory or Relapsed Hodgkin's Lymphoma Treated with High Dose Chemotherapy Followed By Autologous Stem Cell Transplantation: Experience at Skmch Lahore
    Riaz, Shazia
    Ahmed, Mehboob
    Rashid, Aqeela
    Khan, Saghir
    Badar, Farhana
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S127 - S127
  • [28] High-dose therapy and autologous stem cell transplantation in relapsed and refractory Hodgkin's disease: Outcome based on a prognostic model
    Qazilbash, MH
    Devetten, MP
    Abraham, J
    Lynch, JP
    Beall, CL
    Auber, M
    Weisenborn, R
    Bunner, P
    Ericson, SG
    ACTA HAEMATOLOGICA, 2003, 110 (04) : 173 - 178
  • [29] Comparison of CBV, BEAM and BEAC high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation in non-Hodgkin lymphoma: Efficacy and toxicity
    Shi, Youwu
    Liu, Peng
    Zhou, Shengyu
    Yang, Jianliang
    Han, Xiaohong
    He, Xiaohui
    Zhang, Changgong
    Gui, Lin
    Qin, Yan
    Yang, Sheng
    Zhao, Liya
    Yao, Jiarui
    Jia, Bo
    Zhang, Shuxiang
    Sun, Yan
    Shi, Yuankai
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E423 - E429
  • [30] Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphoma
    Robertson, MJ
    Abonour, R
    Hromas, R
    Nelson, RP
    Fineberg, NS
    Cornetta, K
    LEUKEMIA & LYMPHOMA, 2005, 46 (10) : 1477 - 1487
12345